<SEC-DOCUMENT>0001213900-25-010238.txt : 20250205
<SEC-HEADER>0001213900-25-010238.hdr.sgml : 20250205
<ACCEPTANCE-DATETIME>20250205063355
ACCESSION NUMBER:		0001213900-25-010238
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20250205
FILED AS OF DATE:		20250205
DATE AS OF CHANGE:		20250205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALTERITY THERAPEUTICS LTD
		CENTRAL INDEX KEY:			0001131343
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-49843
		FILM NUMBER:		25590776

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 3, 460 BOURKE STREET
		CITY:			MELBOURNE
		STATE:			C3
		ZIP:			VIC 3000
		BUSINESS PHONE:		61 3 9349 4906

	MAIL ADDRESS:	
		STREET 1:		LEVEL 3, 460 BOURKE STREET
		CITY:			MELBOURNE
		STATE:			C3
		ZIP:			VIC 3000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRANA BIOTECHNOLOGY LTD
		DATE OF NAME CHANGE:	20010105
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0230005-6k_alterity.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>



<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Washington,
D.C. 20549</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
6-K</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REPORT
OF FOREIGN PRIVATE ISSUER</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURSUANT
TO RULE 13a-16 OR 15d-163</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNDER
THE SECURITIES EXCHANGE ACT OF 1934</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the month of February 2025</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Alterity
Therapeutics Limited</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant)</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>Level 14, 350 Collins Street,
Melbourne, Victoria 3000 Australia</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of Principal Executive Office)</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
20-F &#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F &#9744;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. <a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020040485/ea130838-s8_alteritytherape.htm">333-251073</a>, <a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020027969/ea127207-s8_alteritytherap.htm">333-248980</a>
and <a href="http://www.sec.gov/Archives/edgar/data/1131343/000114420418063081/tv508429_s-8.htm">333-228671</a>) and our
Registration Statements on Form F-3 (Files No. <a href="http://www.sec.gov/Archives/edgar/data/1131343/000101376223000033/ea185947-f3_alteritytherape.htm">333-274816</a>, <a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020044324/ea132148-f3_alteritytherape.htm">333-251647</a>, <a href="http://www.sec.gov/Archives/edgar/data/1131343/000114420419025615/tv521271_f3.htm">333-231417</a>
and <a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020036934/ea129831-f3_alteritytherap.htm">333-250076</a>)</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; font: 1pt Times New Roman, Times, Serif; border-bottom: Black 2pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALTERITY
THERAPEUTICS LIMITED</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a
development stage enterprise)</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following exhibits are submitted:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="font-style: normal; vertical-align: top; text-align: justify; background-color: rgb(204,238,255); font-weight: normal">
    <TD STYLE="font-style: normal; width: 9%; text-align: left; font-weight: normal">99.1</TD>
    <TD STYLE="font-style: normal; width: 1%; font-weight: normal"><B>&nbsp;</B></TD>
    <TD STYLE="font-style: normal; text-align: justify; width: 90%; font-weight: normal"><p style="margin-top: 0pt; margin-bottom: 0pt"><A HREF="ea023000501ex99-1_alterity.htm">Disclosure under Takeovers Panel GN 20</A></p></TD></TR>
  </TABLE>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>SIGNATURE</u></b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif">&nbsp;</td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Alterity Therapeutics Limited</b></font></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif; width: 4%">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif; width: 36%">&nbsp;</td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">By:</font></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">/s/ Geoffrey P. Kempler</font></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">Geoffrey P. Kempler</font></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">Chairman</font></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-transform: none; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
February 5, 2025</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif">&nbsp;</div></div><!-- Field: /Rule-Page -->



</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea023000501ex99-1_alterity.htm
<DESCRIPTION>DISCLOSURE UNDER TAKEOVERS PANEL GN 20
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ASX ANNOUNCEMENT</B></FONT></TD>
    <TD STYLE="text-align: right; width: 50%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">05 February 2025</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Disclosure under Takeovers Panel Guidance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Note 20: Equity Derivatives</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Alterity Therapeutics Limited ACN 080 699 065
(ASX: ATH, NASDAQ: ATHE) (&ldquo;the Company&rdquo;) advises that it has received the attached notice from Point72 Associates, LLC which
was provided to the Company pursuant to the Australian Takeovers Panel Guidance Note 20 &ndash; Equity Derivatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Authorised for release by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Abby Macnish Niven</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Company Secretary</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Alterity Therapeutics Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For further information please contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Australia</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>U.S. </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Ana Luiza Harrop</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Remy Bernarda</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">we-aualteritytherapeutics@we-worldwide.com</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">remy.bernarda@iradvisory.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">+61 452 510 255</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">+1 (415) 203-6386</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Alterity Therapeutics Limited ACN 080 699 065</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Level 14, 350 Collins Street, Melbourne, Victoria
3000 Australia</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">www.alteritytherapeutics.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 35px; width: 35px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">4 February 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Ms Abby Macnish Niven <BR>
Company Secretary <BR>
Suite 4, Level 14, 350 Collins Street <BR>
Melbourne VIC 3000 <BR>
Australia</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Dear Ms Niven,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>Equity Derivatives of Point72
Associates, LLC in Alterity Therapeutics Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We refer to <I>Guidance
Note 20: Equity Derivatives</I> (<B>GN20</B>) issued by the Australian Takeovers Panel. Terms not defined in this notice have the meaning
given to them in GN20.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">GN20 relevantly provides
that the non-disclosure of long positions, including long equity derivative positions, may give rise to unacceptable circumstances. Point72
Asset Management, L.P. (<B>Point72</B>), as investment manager of Point72 Associates, LLC (the <B>Fund</B>), discloses the below information
on behalf of the Fund, as at the date of this letter, under GN20.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Point72 consents to
Alterity Therapeutics Limited releasing the information contained in this formal disclosure to the ASX. Please provide confirmation to
us once this has been released to the ASX.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 5.4pt; width: 30%; border: black 1pt solid; font-size: 10pt"><B>Identity of the taker:</B></TD>
    <TD STYLE="padding: 5.4pt; width: 70%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font-size: 10pt">Point72 Associates, LLC</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font-size: 10pt"><B>Relevant security:</B></TD>
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font-size: 10pt">Ordinary shares and American Depository Receipts (<B>ADRs</B>) in ALTERITY THERAPUETICS LIMITED</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: justify; font-size: 10pt"><B>Price (including reference price, strike price, option price etc as appropriate):</B></TD>
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid; font-size: 10pt">Not applicable.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font-size: 10pt"><B>Entry date and number of securities to which the derivative relates:</B></TD>
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">Total number of securities to which derivatives relate as
    3 February 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.4pt; text-indent: -0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
    </FONT>187,910,474 ORDs; and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 53.95pt 0pt 41.4pt; text-indent: -18.05pt"><FONT STYLE="font-family: Wingdings">&sect;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
    </FONT>135,120 ADRs (which, when converted, represents 81,072,000 ORDs)</P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 35px; width: 35px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 5.4pt; width: 30%; border: black 1pt solid"><B>Type of derivative (e.g. contract for difference, cash settled put or call option):</B></TD>
    <TD STYLE="padding: 5.4pt; width: 70%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">With respect to the:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.35pt; text-indent: -17.95pt">-<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>187,910,474 ORDs: cash settled equity swap</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.35pt; text-indent: -17.95pt">-<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>135,120 ADRs: cash position in the ADRs</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"><B>Any material changes to information previously disclosed to the market:</B></TD>
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid">Following the issue of shares under the private placement announced by ATH on 3 February 2025, the number of securities to which the derivatives relate now represent 4.90% of the securities in ATH, falling from 5.05% when the information was previously disclosed to the company on 4 February 2025.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"><B>Relevant interest in the securities:</B></TD>
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid">None</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"><B>Long equity derivative positions held by the taker and its associates:</B></TD>
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid">The Fund has no other associates with a long equity derivative position or relevant interest in the company</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"><B>Short equity derivative positions that offset long positions</B></TD>
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid">None</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"><B>Short positions of more than 1% that have been acquired after a long position is disclosed, whether by notice or substantial holding notice.</B></TD>
    <TD STYLE="padding: 5.4pt; border-right: black 1pt solid; border-bottom: black 1pt solid">None</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Yours sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">/s/ Vincent Tortorella</TD>
  <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Vincent Tortorella</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">General Counsel and Chief Compliance Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Point72 Asset Management, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #1 -$# 2(  A$! Q$!_\0
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M;5_#?@W4[S2KF\LM,M["*4:M<0Z;?7SV,NI"]2&2SOOL]W"U@5EMXR>?Z8:
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MHFO6VMW[6%I$L>E7V@:3H]@VD0LLUQ9*UO-<[;UVENI0R!?T&3XN_"F3Q2?
M\?Q+\!/XS4A3X43Q=H#>(A(8XYA$='%^=0$S0S13+";?S6A=950QG=0!^.7_
M  70_P""K^K_ /!+_P"!7@_4? 'AZW\0?%[XO7OB#1_ CW\MDFE:&_A__A'V
MU/5K^&]L-5CNS;6FOBZM+.33I8;R>S^S336\<IF7X@_X($_\%T_BS_P43^*/
MCW]G7]HO1M+/Q&T#P%JWQ,\/>,=$M]&TRQU+1M)\6>%/#=SI%SI&D:-HMO;W
M:R^-]/\ )D1;LRPZ9+,[QR3L@_5#_@K=_P $U?@1_P %'O@3IGA;XR>-9_AC
M?_#R\O\ 6/!WQ%CUK1="MO#UUJLNC/J2:E>:]I&LV)L=1CT.SL[A1;QSFW>=
M()XI7CDC^1O^"+O_  1H_9O_ ."?'B;Q[\:/AY\;K?X]_$/Q/X;O?A_+X@T?
MQ-X:U_P]H/AJ_P!>T+7KRPACT30-*NK>_N-0\(Z+*6N[J="8;LQQ;)(O* /Z
M&**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **_/#_@HY_P
M4G^ _P#P33^$6G?%#XSOJ>J7GB._N],\'>#- A,NO>);NQBMVOGLVE1+"*WL
M);_2XKI[V\LU!U" I(5$C1^(?\$O_P#@LK^SC_P5"7Q?H_PRTSQ%X(\?>";>
M?5-6\$>+8H1J4V@1W.EVB:Y9W.GO>Z5):O=ZO;6GV8:G)?B6.:4VRP+O !^O
MU?C=_P %Y?&G[0?@+_@FQ\<O$'[.<WB.P\6PV^@PZQK'A"YU6S\3Z/X;G\1Z
M1#>W>CW>BJ-1@EEE>"RNFAN;,-I]S=I),T3/!+^R-?.G[5_[0/P@_9@^ GQ!
M^,_QTN[:W^&OA+2HIM?@N;.34/[0COK^STRVL8;"&VO);J:>\O;=55+>3RQF
M=C&D32( ?YF7_! #XJ?M,0_\%-/@79?#CQ5X^UC3/$_C3P[:_%?31XA\1W6D
M:EX&NO$%C!XHU+Q%9I/<VFH/I^@WFN7%K<:I"XMS)=NEQ;^9-(?T-_X.POB+
M^U!8_M>^%?".MZMXRT+]GZ#PQHE]\,[;3=5UVQ\*ZSJ)T2V.KZE=VD#6ND7.
MNVFMW7BBP@N2+R[CL(Y85GBC\RW7]PO^"7?_  61_P""97[1/[3-]\'_ (+_
M  "OO@%\1_'UV%\-Z]KFG12Q>+[P3WZ6]C;7-AJ&N+IUW/<7L%O"DJ:1#+-J
M<0"LD3BW^B_^"R__  4__8(_8\N/!GPN_:;^%$OQ\\9ZN;77[+P1I%HK7V@6
M!BU%$U2]U&>]T:W@0+(B+9+J_GR+JMO<"SDB626( _.__@W1^)/[76K?\$LO
MVL[T7GC3Q1J/A'PO\19/V;9_$E_K^L7+^+[+X<7\VAZ+X>;4%O9!IUMJ5OX8
M&G:?I;2PH]R5M[1&E E_BXU;XW?MA6W[9&L^,3\0/C'8_M$GXGZA'<W.G>*O
M&<7C*#6([][:32[6>&^AUI;6TL($L[2SC:..#3+:WMXH8[:&.)/]2+_@G#^W
M9^R1^UC^RI/\7OV?;&V^'?PU^']M?VGC#PIJ&G2Z=/X&30-!M-4U0:H!#)%>
M0V6GET>]M+G4X[@6,WE75P%!/X@3_P#!>O\ X)"V7[:^IZ=>_ *]AUBT\23^
M&KG]H4^'6N=!.JV"66G37IT6*XFU26U2YLGTX3P^$WEFEMDN4>6VE-U.P.3_
M .#F[XF?M>>'/V#/V7QH6H>,O"_AOQ8^N1?M$77AN]U[22M_&? Y\.Z?XAGT
MX6@BM+K5+F^M8[;495CN_/NK98&#R(WP/_P:,?$G]HK5/VIOC3X*?7O&>M_
M-/@CX@UK6;'5-8UR]\*:9\0(?B!\++?1KBWMKF2YTF#79-"U+Q.T"JEO>2VD
M^I2)*4-P&_K8_P""F?[>/[(W['W[-"?$3]HW3+?XB^#_ !RDECX1\"6-BU[?
M^-G\W3;>Z&F-+'%;VD=D-6L+B>:ZO=./E.&@F\R,F/Y7_P""-7_!3#]A#]M
M^.OAS^RY\*9O@9XT\,:9=>*M:\#ZG8*FH:MX=@UFPT^ZURVU*WN=6M9+6WU+
MQ#H\,MI+K'VHS:C$T5GY4$IMT!^\U%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ?SE_\'#O_!*7XM_\%)/A+\)/$'P*U"UF^)/P(?XA7%AX
M1U*9[:Q\4:=XVA\&SWT<5TET#%J%L_@>TALX(]+U*:Y>_?RQ"T>RX^//^#=7
M_@B]^TC^PM\5/B1^T/\ M+QV?A36->\'W7@7PSX)TV>YGGDA?5M!U0ZSJMQ.
M]A*D;&TU&VCTZ31W7*6UZM_EE@7Z-_X.3O\ @IO^T!^P!\(_@GX3_9SU.Y\'
M^-?CC>_$(7?Q AT;1=9&@:5X'C\$6\]@D.OVFJ:;'<:O_P )OO@:72KER^F-
MLFMPKK-\4_\ !MM_P5Y_:N_:T^*_Q7^ ?[3OC#4/BM#H/@+4?B#X;\5R>'/"
M^D7VG2V^JZ'9-I%P?#&E:!:26IBEU&6%IK*>X-S=1QF?RE18P#^T"OS2_P""
MM/[$.L_M_P#[%7Q,_9_\*Z\OA[QIJ@TK5O"%[<(9=-?5],U6QN7MM3@_M#34
MFMI].2]CC$ER%CNF@F"2/&J-_$G_ ,%._P#@X"_X*":)^W5\7O"7P.^*6J?!
M_P"'/P3^*OC'P%H7@Y?!G@*_&K)X)\8W^D#5=4G\2>'/$.HR2:K!I-NTR1:A
M% -\ODV\&XBOZ2OB#_P5P^,VA?\ !"?P=^W[9: (/C?XWT*^TFVGCTJVETO3
M-;TOXIZ[X)EUV\L9)FMXH+O2/#\LX BFA&H7L02VCB95C /Q5_X) _\ !O/^
MVI\%_P!N'X=_&[]HG2]'\ ^!?@9XU\.>,+6:RN[O4+KQ9JWAO7X=<T^VTY9X
M]&5].EN="MXKJ[@;4(U@OXY&MWPL<OU]_P '"7_!#C]IG]L']H73/VI/V7XK
M;QS>>)=+T30O&_@G4)+FVNM(NM(T.WT2UU+2);>75)I[(V/A_2_M%O'H]I']
MJU&:5[HO#BX_.O\ X(U?\%UOV_/B3^WQ\*?A%\>?BI?_ !?^'OQM\;>'_!6H
MZ#=^$? VEMH=YXH\0VFA6>LVEUX9\.>'KZ.#2Y=<-W<"2\GC$=K'NMIP&C?[
M/_X.-?\ @LE^V!^S#^TYI?[,W[,_C.^^$.E>%=#T/6_$?B>#PUX5U>\\4:CJ
MVB6FM1K8R^*-)\0V_P#9L%KXAM[2Y:&TLIEOM,\M=R&628 _3C_@C1_P2#^)
M_P"R9^P/^T-\#/V@-?MM)\=?M2>%/%WA?7--T1'OK?P5HWBWP3J'AN.1)3J5
MNU]J5G+K^HM/"\&BS/\ 8X [PF4-#_,EJG_!KQ_P4"?]J/5/!>G6WAE?A,/%
MTVH6'Q9GFG>U;P[-+#J5O,^F^<+*348Q=)8SV7_"3^8)8+F5I1)%);K_ $>?
M\$1O^"K?QW_:3_X)Z?M*_&/]H)7^(7C_ /9>\+^-O%46N6NCZ=IUQXTTSPKX
M$U#Q#9:3+::,FC:<^HSW/AZZ$R6EIIX+:E&BSJNSR?Y7=0_X..O^"F,7[4&K
M?$.T^+BKX);QI=VUG\);_P &^!(]!@T%+M-/L])NKR+PQ_PDBS0V]O#+/(NO
M-/\ ;/,3[2T)VT ?UD_\%PO^"/'Q+_;=_9/^!'@SX#Z_;ZA\0?V9K/Q"-"T/
M6Q):VWC*TUBW\,V]U']I749&L+^*TT"X:UB6SUB2]N)X;=!"RJ[_ !__ ,&Z
M?_!%C]I[]AKX[?$/]I;]I>"R\'W6K?"S7?A?X:\%:?<7-Q=7?]L>-? GB276
M=3GG;3Y;>*W'@:2"*Q?2)DNH]0@NQ?0B)8;CZ'_X+V_\%8?CU^R/^R!^SUXC
M_9Z^V> _'?[2MOKLTOB\Z)I&JR^#++1$\*7<UK'::]%K&FI<:C:ZU>V6;K3[
M\HQC:*2&11)7QQ_P;5_\%=_VN/VN_P!H;XD_LW?M->-[OXIZ?:?"77_B9X<\
M4W?AWPOH]]I%_H_CCX?>'!I;OX6T?0;62TNH/&M[.QN;.YF#VD.R>- R. ?V
MI4444 %%%% !1110 4444 %%%% !1110!^('_!97_@LKX&_X)9>"_!UA:>%%
M^(OQF^)+ZA+X3\(/K(T2SM=%TFW']JZ[J%\-$U\$6=]?:';QZ=):VS7<>HM.
MEW&MN5E\_P#^"-/_  7'\%_\%.-*\>^$_%_@N+X6?&+X<V]QKVIZ+%KJZUI.
ML>#DL;.>'7;.]?0?#T5O<?:X]>AN=,1;V2VMM)6^EN?*NU6"3_@M[_P1:7_@
MJ7X?^'GBKP'XTTCP-\9_A<FL:=H=WXHO=9MO"NJZ#KT5O+J5KJ/]DZ1XBN4N
MQ?:1H9MFATC/V>*[S<QN1'/YY_P1-_X(42_\$TG^(OQ%^+OCO0O'OQ:^(VCS
M>$IK;P=?:Y<>$]'\*&TB11#-JVA^%;]]6N+B]UZ&Y673IX8[.:RD@NOM&];<
M ^!/VO?^#KNQ^!O[5_CCX.?#'X 0>//AO\+O'&M>!?$OBF\\=KI%]KNJ>%]6
MET/Q"VF6;> ]3-C;VVI:=J$=I.EWJ45Y#)#<1/L4!_W>_:3_ ."M/P#_ &?O
M^"?^D_MYR177B#PKXVT"TN_AQX8CN38ZAXFUN_\ $%GX833TN!I]_-%'97UV
MU[=3QZ3=#[!:2S210P%IXOYO_P!L7_@U1^(7Q6_:S^(GQ,^$WQ\^%/AOX:?%
M?XA^*?B!J&C^-=>\4VOC'0[KQCK]SXBU6RL;.Q\!ZYI\T%O>:I=Q::9M7F>2
MVB@,[1NS ?OU^U%_P1W^&?Q[_P"";'A7]@;3O%=UH2?#+1;)?AWXVO;J\5=.
MUNS\567BF>YU(I'?>;87WV>YTN<S:=?O!97336MO%<QQ2Q@'YP_\$J?^#E;2
M/VX/VB+;]G?XR_"&#X7:]XZU#3K'X9:OI?BH:_:WFI:CJJZ9!H-_;+X1T5?M
M$LNHZ7'%>M?(7,4[K9D.PB]'_P""PG_!P_H/_!/#XP67[/?PJ^&,'Q2^).F6
MUAJ?CJ[U#Q*-#T[P[%>/>.ND+;GPOKJ7-Z]K#97/FF]MI$CU*-OLK+!NG^7O
M^"3'_!M=XP_9#_:CT3]HWX[?&?X=^,Y/A=K%CJO@+0/A=K/B'5([C6=+UN#4
M[34/$#ZUX/\ "KP)$^DV?V>*WN;F*9;B[%S:DQ1"O3/^"S__  ;P^(?V[OC\
M?VE_@C\6_ O@/Q;XFL]*T[QQH7Q,U?7M,T>^N;.6YM_[5TB?1_"WBJ?[7]@;
M3K<VS&QM-EI+((#,Q>8 ^N/@GXS_ &-_^#D/]B2%?BMX%O\ 0=>\%?V?;>*=
M)T_4]/O/$7P\\8Z_IES;SW>@^(;WPW:S)87^J>']1>%[;3+);M-'M9HKEPB-
M']K?\$[/^"2O[*G_  33L/$3_ G2M9OO%7BZVGL/$/C+Q7/I^HZ]>:7+=V-X
MFDQ7T.FVMW%IL4VFV<RV<ES/#]H22<*&<!.2_P""/?\ P3#T+_@F%^SM=_#E
M?%5KXW\?>.I="UOXB>)=+N;VYT*[U73+?4YH;306O+/2G?2+&\\0:RFGW,FD
M:?>75G);R7R-, L7ZV4 ?AG^UY_P;[?L%_MC_'ZU_:&\?:+XK\/>+;[7)M=\
M<V'@^_TC2-&\<7=SJL&K7<VL6JZ)(T]Y?S_VA]ON[Z34&NC?R-(F1()OTBUC
M]BW]G;6_V7)/V.+WP!I/_"@GT!?#B^#(K#24LX[%=<'B4R1VQTUM-6[?7=VJ
M23C3OGO9)+@H)G,E?55% 'XC?L3_ /! W]AC]AGXW7OQ[^&FE>+?$/C:"[>?
MPDWC34=+UFS\(QM-=3)_9<9T>*6&[C,UNR7=I-9E9+*VD$?[N-4]=_X*+?\
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MHH ^#O\ @IK^RCXE_;?_ &(/C;^R]X0\4?\ "&>(OB=_PK;^SO$NR.3^S?\
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ML=9L%L8+"."74)_"^JWE[8II5C:V+7$$%FUQ$#Y7[64 %%%% !1110 4444
M%?GA_P %5?V8?'7[87["GQU^ GPTOGL_&_C+PZ8O#\/VFTM+?5+R,M$--OI[
MZ>UM5LY4N'N'$MU;*9;6']\#A6_0^OBC_@H=^UQ9_L._LC?%O]I&XTA]>O/
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MO&UI&]GXB\2_\)1!X@'BW4@+/1K@74.I001SQ*FFVUO]G2*VAMXX((DBCC0
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MG^T[<RM%/9FT$\4UM=1LF86R ?HU7B/[1WQW^&W[,_P5\??&[XN:C%I?P_\
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ML:9X'MK&0QZ786]FCG4[[4[N*RTV-"FJZ<B6L6N1W4R:@)$MI$@GDM_YY?\
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M %%%% !1110!^0G_  5[_P""57PC_P""GGPC\*Z)XZ\7R?#GQG\+9?$M_P"
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M/AFP"BUT7PYIMMIEC&5BB@$C1VZ*9IC%#%&\\S232+&F^1MHKMJ** "BBB@
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0@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !7 0X# 2(  A$! Q$!_\0
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MV_7_ .M1YGM^O_UJCHH D\SV_7_ZU'F>WZ__ %JCHH D\SV_7_ZU'F>WZ_\
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MJ:49N$8R:3U2;:=UT*C*,U>+NOZZ&_17QM\6_P#@HA^PA\!O%<G@7XR?M?\
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M-&*DXM--:7"$XSCS)Z:[Z-6=M==#VVBN+^'OQ(^'WQ:\):7X^^%OCCPG\1O
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MP<?MG?!4GDC/PY\<#)]"PU(G!.,\''4#U^5O^#=3X_>,OV /^"M/BO\ 8_\
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M\5Z.;CP/XKU#P9XEL;";0_'O@+Q+-::1JNI6UC!]MLX-<M[&Y?1]7CA7@_\
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MA.S-F;00,3<W/G%P(@O]M'_!0_\ X)K^%OB+_P $:/%/[$?A%]6\7ZG^SM\
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MWGAC[=;:/#X=\473Y\_5["2:)M(U&1S<:EIL5S%=[[C3S<W7[KUYV7<;<>>
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M KQ#]E?XN>,?C/\ LN? GXW?%3P6WPL\;_$;X/>"/B#XZ\$7J7EFO@[6]?\
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MT[3[6WL;"PLH(K6SLK*TB2"UM+2V@5(;>VMH(XX8((42*&)$CC544 ?SJ?\
M!-3]NO\ :O\ VRO'G@^Y\7_M=?!*S:3Q]\5(_%?[.6D?L;_$ZQUZ3P3\./'/
MB?PV+.Q^/UQXS'P^BU34-'TG3]7-[!97DT$MS)I_]G37<4J+^EG[0'[2_P 2
M_AM^WU^P#^SCX;;P^/AQ^TCI'[45Y\1UU#2GNM>:X^$?PXTCQ3X1_L#5!>0I
MI:#5+V?^U%>TO/MMMLA4P%2Y*F&K0J>PE)2E"G4J<O-/EC&$)5)\O/&*NXQ;
M7)'EF]I/<%)-76U[?.]OS?7\#ZP^(WP$^!GQAO--U'XM?!KX5_$_4-&MIK+1
M[[XA?#_PIXRN]*L[F43W%KIUSXBTG49K*WGF599H;9XHY955W5F (]/L;&RT
MRRL]-TVTMM/T[3[6WL;"PLH(K6SLK*TA2WM;2TMH%2&WMK:"..&""%$BAB1(
MXU5% 'P=^Q3^T?\ $?X]?$G]O3PMX\;06TK]G3]L/Q)\$/AU_8NEOIUP/!&E
M?#CX=>*+8:[,UW<C5-8&J>*-4$M^B6BM;BWA^S*8B[_''P_^(G_!2R^_X*0^
M*OV5/$_[3O[/>I_#3X>?";X<?M&ZY)IW[,&IZ7K_ (C\"^-OBCXK\(7'PVLM
M3?XPWB:-K=II/A9]GC-[74(GN;U9O^$?40%)1X:KS5*<ZE.+H4HUW&523CR3
MA2J>YRQG'FM6IJ4;0]Z33;Y9-.ZT=MW;;7K_ ),_3;XG_L??LG?&SQ&OC#XQ
M?LS_  %^*?BQ88+<>)OB#\)/ GB_7S;VRA+:!M8U[0K_ %!XK= $AC>X9(D
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MSZII%Q?P.LD&N:]+=6=FEQ':LJO9:1Y,D<EP!->MY<2VTW[&@         8
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##__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
